Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Jan 7;22(1):155-64.
doi: 10.3748/wjg.v22.i1.155.

Association between hepatitis B and metabolic syndrome: Current state of the art

Affiliations
Review

Association between hepatitis B and metabolic syndrome: Current state of the art

Peter Jarcuska et al. World J Gastroenterol. .

Abstract

Chronic hepatitis B (CHB) is a global health issue that increases the risk of liver cirrhosis and hepatocellular carcinoma in infected patients. Metabolic syndrome (MetS) is a disease endemic mostly to the developed countries. It is associated with high cardiovascular mortality and morbidity, diabetes mellitus as well as cancer. In this manuscript, we systematically review the published data on the relationship between MetS and CHB infection. Multiple studies have described highly variable correlations between CHB on one hand and MetS, non-alcoholic fatty liver disease and dyslipidemia on the other. No association between CHB and diabetes mellitus or atherosclerosis has been described as of now. The presence of MetS in patients infected with hepatitis B virus increases the risk of fibrosis, cirrhosis and hepatocellular carcinoma. Appropriate lifestyle, but also pharmacological interventions are needed to prevent the development of these complications.

Keywords: Cirrhosis; Fibrosis; Hepatitis B; Hepatocellular carcinoma; Metabolic syndrome; Nonalcoholic fatty liver disease.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Association between total cholesterol and hepatitis B virus DNA load. Adapted from Janicko et al[14] (2014).

References

    1. Lok AS, McMahon BJ. Chronic hepatitis B. Hepatology. 2007;45:507–539. - PubMed
    1. Kane M. Global programme for control of hepatitis B infection. Vaccine. 1995;13 Suppl 1:S47–S49. - PubMed
    1. Alberti KG, Zimmet P, Shaw J. Metabolic syndrome--a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med. 2006;23:469–480. - PubMed
    1. Colangelo LA, Gapstur SM, Gann PH, Dyer AR, Liu K. Colorectal cancer mortality and factors related to the insulin resistance syndrome. Cancer Epidemiol Biomarkers Prev. 2002;11:385–391. - PubMed
    1. Chen CL, Yang HI, Yang WS, Liu CJ, Chen PJ, You SL, Wang LY, Sun CA, Lu SN, Chen DS, et al. Metabolic factors and risk of hepatocellular carcinoma by chronic hepatitis B/C infection: a follow-up study in Taiwan. Gastroenterology. 2008;135:111–121. - PubMed

MeSH terms